TIDMKMK
RNS Number : 6653W
Kromek Group PLC
19 April 2023
19 April 2023
Kromek Group plc
("Kromek" or the "Group")
Kromek and Analogic Announce Collaboration Agreement to Develop
Next Generation
Computed Tomography (CT) Detector Technology
CZT-based Photon Counting CT technology is poised to enable
imaging and detection breakthroughs
not achievable with conventional technology
Kromek Group plc (AIM: KMK) and Analogic Corporation today
announced they have entered into an agreement to collaborate on the
development of next-generation Cadmium Zinc Telluride (CZT) based
detector solutions for Photon Counting Computed Tomography (PCCT)
applications in the medical imaging and security sectors.
CZT-based PCCT detectors overcome limitations inherent in
conventional CT detectors to deliver improvements in spatial
resolution, radiation dose reduction and energy resolution. This
innovative technology can result in improved image quality whilst
also providing a gateway to material characterization and
quantitative results allowing early detection of life-threatening
illness such as breast cancer or heart disease when used in medical
imaging. In security screening, the improved image quality and 3D
images of passenger bags and parcels will allow passengers to keep
luggage in their bag whilst accurately identifying prohibited and
dangerous items in real time.
As part of the collaboration, Kromek will integrate CZT sensors
with Analogic's detector designs to ensure optimal detection system
performance. As the project progresses toward commercialisation,
the Group will ensure production capability is available to support
Analogic's PCCT demand.
As global leaders in CT detector technology for over 50 years,
Analogic continues to advance its product offering of systems and
subsystems in both security and medical imaging applications. Its
PCCT technology is designed to enable new system solutions as well
as upgraded options for installed systems.
Arnab Basu, CEO of Kromek, said : "At Kromek we are constantly
looking to team up with leading global organisations who match our
vision and desire to improve patient outcomes as well as combine
our technologies to enhance the safety of our citizens. Analogic
has a long track record in doing just this and we are looking
forward to our collaboration to enable Analogic to bring the next
generation of CT scanners to the market."
Tom Ripp, Analogic CEO, said: "As pioneers in CT imaging and
detection technology, we are excited about this collaboration with
Kromek to bring the next generation of PCCT detection solutions to
market." Mr. Ripp continued: "This project underscores Analogic's
desire to make the world a healthier and safer place for patients
and passengers globally."
For further information, please contact:
Kromek Group plc
Arnab Basu, CEO
Paul Farquhar, CFO +44 (0)1740 626 060
finnCap Ltd (Nominated Adviser and Broker)
Geoff Nash/Emily Watts/Seamus Fricker/George
Dollemore Corporate Finance
Tim Redfern/Charlotte Sutcliffe - ECM +44 (0)20 7220 0500
Gracechurch Group (Financial PR)
Harry Chathli/Claire Norbury +44 (0)20 4582 3500
Kromek Group plc
Kromek Group plc is a leading developer of radiation detection
and bio-detection technology solutions for the advanced imaging and
CBRN detection segments. Headquartered in County Durham, UK, Kromek
has manufacturing operations in the UK and US, delivering on the
vision of enhancing the quality of life through innovative
detection technology solutions.
The advanced imaging segment comprises the medical (including CT
and SPECT), security and industrial markets. Kromek provides its
OEM customers with detector components, based on its core cadmium
zinc telluride (CZT) platform, to enable better detection of
diseases such as cancer and Alzheimer's, contamination in
industrial manufacture and explosives in aviation settings.
In CBRN detection, the Group provides nuclear radiation
detection solutions to the global homeland defence and security
market. Kromek's compact, handheld, high-performance radiation
detectors, based on advanced scintillation technology, are
primarily used to protect critical infrastructure and urban
environments from the threat of 'dirty bombs'.
The Group is also developing bio-security solutions in the CBRN
detection segment. These consist of fully automated and autonomous
systems to detect a wide range of airborne pathogens.
Kromek is listed on AIM, a market of the London Stock Exchange,
under the trading symbol 'KMK'.
Further information is available at www.kromek.com.
Analogic Corporation
Analogic Corporation, headquartered in Peabody, MA, USA, is a
global leader in design, development manufacturing and support of
technically advanced and cost-effective imaging & detection and
power & automation solutions for security, healthcare, and
other high-end industrial markets. Analogic has been a leader in
the field of Computed Tomography for over 40 years, with technology
installed in over 60,000 CT systems deployed worldwide. For more
information, please visit www.analogic.com.
Contact:
Jason Plante +1 (216) 645-6113
VP, Medical Imaging
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
MSCEANLPFLDDEFA
(END) Dow Jones Newswires
April 19, 2023 02:00 ET (06:00 GMT)
Kromek (LSE:KMK)
Historical Stock Chart
From Jun 2024 to Jul 2024
Kromek (LSE:KMK)
Historical Stock Chart
From Jul 2023 to Jul 2024